Urotheelcelcarcinoom - Med-Info
Urotheelcelcarcinoom - Med-Info
Urotheelcelcarcinoom - Med-Info
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Richtlijn: Urotheelcarcinoom van de blaas (1.0)<br />
Martinez-Pineiro JA, Jimenez Leon J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, et al. Bacillus<br />
Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with<br />
superficial bladder cancer. J Urol 1990; 143: 502–6.<br />
208 - Martínez-Piñeiro JA<br />
Martínez-Piñeiro JA, Martínez-Piñeiro L, Solsona E, Rodríguez RH, Gómez JM, Martín MG, et al. Has a<br />
3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression<br />
of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol<br />
2005; 174: 1242-7.<br />
209 - May F<br />
May F, Treiber V, Hartung R, Schwaibald H. Significance of random bladder biopsies in superficial bladder<br />
cancer. Eur Urol 2003; 44: 47-50.<br />
210 - Melekos MD<br />
Melekos MD, Chionis HS, Paranychianakis GS, Dauaher HH. Intravesical 40-epi-doxorubin (epirubicin)<br />
versus bacillus Calmette-Guerin. A controlled prospective study on the prophylaxis of superficial bladder<br />
cancer. Cancer 1993; 72: 1749–55.<br />
211 - Meyer TJ<br />
Meyer TJ, MarkMM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of<br />
randomized experiments. Health Psychology 1995; 14: 101-8.<br />
212 - Miladi M<br />
Miladi M, Peyromaure M, Zerbib M, Saighi D, Debre B. The value of a second transurethral resection in<br />
evaluating patients with bladder tumours. Eur Urol 2003; 43: 241-5.<br />
213 - Miller MI<br />
Miller MI, Benson MC. Management of urethral recurrence after radical cystectomy and neobladder<br />
creation by urethroscopic resection and fulguration. J Urol 1996; 156: 1768.<br />
214 - Mills RD<br />
Mills RD, Studer UD. Metabolic consequences of continent urinary diversion. J Urol 1999; 161: 1057-66.<br />
215 - Mills RD<br />
Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node<br />
metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic<br />
lymphadenectomy. J Urol 2001; 166: 19-23.<br />
216 - Mommsen S<br />
Mommsen S, Jacobsen A, Sell A. Quality of life in patients with advanced bladder cancer. Scand J Urol<br />
Nephrol Suppl 1989; 125: 115-20.<br />
217 - Moonen L<br />
Moonen L, van der Voet H, Horenblas S, et al. Feasibility study of accelerated fractionation in radiotherapy<br />
of carcinoma of the urinary bladder.Int J Radiat Oncol Biol Phys 1997; 37: 537-42.<br />
218 - Morgia G<br />
Morgia G, Falsaperla M, Madonia M, Vacirca F, La Pira G, De Grande G, et al. Use of BCG in<br />
immunotherapy of superficial bladder cancer: multicentric investigation on safety and compliance. Uro<br />
Oncol 2002; 2: 129–35.<br />
219 - Mostofi FK<br />
Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International classification<br />
of tumors 19. Geneva: World Health Organization, 1973.<br />
220 - Murphy WM<br />
Murphy WM, Takezawa K, Maruniak NA. Interobserver discrepancy using the 1998 World Health<br />
Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical<br />
choices for patient care. J Urol 2002; 168: 968-72.<br />
09/17/12 Urotheelcarcinoom van de blaas (1.0) 78
Change language